Implementation, utilization, and evaluation of a pharmacist-driven romiplostim dosing service for patients with immune thrombocytopenia at a multisite cancer centre.

Moore, Donald C; Elmes, Joseph B; Gebru, Tsion; Lavery, Lesli A; Pellegrino, Annie; Plesca, Dragos

Moore, Donald C; Elmes, Joseph B; Gebru, Tsion; Lavery, Lesli A; Pellegrino, Annie; Plesca, Dragos.

Afiliação

Moore DC; Department of Pharmacy, 536516Levine Cancer Institute, 100 Medical Park Drive, Concord NC 28025.
Elmes JB; Department of Pharmacy, 536516Levine Cancer Institute, 100 Medical Park Drive, Concord NC 28025.
Gebru T; Department of Pharmacy, 536516Levine Cancer Institute, 4525 Cameron Valley Pkwy, Charlotte, NC 28211.
Lavery LA; Department of Pharmacy, 536516Levine Cancer Institute, 10660 Park Rd, Charlotte, NC 28210.
Pellegrino A; Department of Pharmacy, 536516Levine Cancer Institute, 1656 Riverchase Blvd, Rock Hill, SC 29732.
Plesca D; Department of Pharmacy, 536516Levine Cancer Institute, 1021 Morehead Medical Dr, Charlotte, NC 28204.

J Oncol Pharm Pract ; 28(3): 613-617, 2022 Apr.

Article em En | MEDLINE | ID: mdl-35060795

Assuntos

Neoplasias; Púrpura Trombocitopênica Idiopática; Humanos; Neoplasias/tratamento farmacológico; Farmacêuticos; Púrpura Trombocitopênica Idiopática/induzido quimicamente; Púrpura Trombocitopênica Idiopática/tratamento farmacológico; Receptores Fc/uso terapêutico; Proteínas Recombinantes de Fusão/uso terapêutico; Estudos Retrospectivos; Trombopoetina/uso terapêutico; Resultado do Tratamento

Palavras-chave

clinical pharmacy services; immune thrombcoytopenia; romiplostim

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Evaluation_studies / Guideline / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google